Chemoinformaics analysis of 3-hydroxy oleic acid
| Molecular Weight | 452.544 | nRot | 20 |
| Heavy Atom Molecular Weight | 410.208 | nRig | 4 |
| Exact Molecular Weight | 452.27 | nRing | 0 |
| Solubility: LogS | -4.207 | nHRing | 0 |
| Solubility: LogP | 5.071 | No. of Aliphatic Rings | 0 |
| Acid Count | 2 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 72 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 30 | No. of Aromatic Carbocycles | 0 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 42 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 22 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 73.7443 |
| nHD | 3 | BPOL | 54.5597 |
| QED | 0.102 |
| Synth | 3.948 |
| Natural Product Likeliness | 0.615 |
| NR-PPAR-gamma | 0.016 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.328 |
| Pgp-sub | 0.199 |
| HIA | 0.078 |
| CACO-2 | -4.947 |
| MDCK | 0.0000366 |
| BBB | 0.175 |
| PPB | 0.961361 |
| VDSS | 0.786 |
| FU | 0.0153728 |
| CYP1A2-inh | 0.052 |
| CYP1A2-sub | 0.117 |
| CYP2c19-inh | 0.257 |
| CYP2c19-sub | 0.061 |
| CYP2c9-inh | 0.498 |
| CYP2c9-sub | 0.988 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.042 |
| CYP3a4-inh | 0.341 |
| CYP3a4-sub | 0.029 |
| CL | 2.107 |
| T12 | 0.793 |
| hERG | 0.005 |
| Ames | 0.005 |
| ROA | 0.003 |
| SkinSen | 0.948 |
| Carcinogencity | 0.433 |
| EI | 0.052 |
| Respiratory | 0.325 |
| NR-Aromatase | 0.003 |
| Antiviral | Yes |
| Prediction | 0.757074 |